Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Free Cash Flow (Quarterly): -11.08M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -11.08M |
| June 30, 2023 | -10.05M |
| March 31, 2023 | -18.63M |
| December 31, 2022 | -9.948M |
| September 30, 2022 | -7.289M |
| June 30, 2022 | -8.452M |
| Date | Value |
|---|---|
| March 31, 2022 | -7.711M |
| December 31, 2021 | -9.914M |
| September 30, 2021 | -5.321M |
| June 30, 2021 | -6.758M |
| March 31, 2021 | -5.20M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-18.63M
Minimum
Mar 2023
-5.20M
Maximum
Mar 2021
-9.123M
Average
-8.452M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -111.86M |
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |